Provided by Tiger Trade Technology Pte. Ltd.

Ironwood Pharmaceuticals

4.29
+0.15003.62%
Post-market: 4.340.0500+1.17%19:46 EDT
Volume:2.27M
Turnover:9.70M
Market Cap:706.19M
PE:5.44
High:4.30
Open:4.22
Low:4.19
Close:4.14
52wk High:5.78
52wk Low:1.01
Shares:164.61M
Float Shares:136.00M
Volume Ratio:1.41
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7890
EPS(LYR):0.1484
ROE:-574.72%
ROA:47.02%
PB:-4.36
PE(LYR):28.91

Loading ...

Ironwood Pharmaceuticals’ Earnings Call Highlights LINZESS Surge

TIPRANKS
·
Aug 07

Ironwood Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Ironwood Q2 FY26 GAAP Net Income Rises 117% to $51.29 Million; Revenue Increases 33% to $113.04 Million

Reuters
·
Aug 06

Ironwood Pharmaceuticals Q2 Revenue USD 113.041 Million Vs. IBES Estimate USD 114.8 Million

Reuters
·
Aug 06

Ironwood Pharmaceuticals Outlook FY Revenue USD 460-485 Million

THOMSON REUTERS
·
Aug 06

Ironwood Pharmaceuticals Q2 Adjusted Net Income USD 51.495 Million

THOMSON REUTERS
·
Aug 06

Ironwood Pharmaceuticals Q2 EPS USD 0.31

THOMSON REUTERS
·
Aug 06

Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results

THOMSON REUTERS
·
Aug 06

Press Release: Ironwood Pharmaceuticals to Host Second Quarter 2026 Investor Update Call

Dow Jones
·
Jul 31

Ironwood Pharmaceuticals’ Jeffrey Silber, SVP and CMO, Files Initial Beneficial Ownership Statement

Reuters
·
Jul 23

Ironwood Pharma (IRWD) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Jul 16

Ironwood CMO Michael Shetzline to retire, Jeffrey Silber to succeed

TIPRANKS
·
Jul 14

Ironwood Names Jeffrey Silber Chief Medical Officer, Succeeding Michael Shetzline

Reuters
·
Jul 14

Ironwood Pharmaceuticals - Initiates Phase 3 Stars-2 Trial of Apraglutide in June, NOW Recruiting Patients

THOMSON REUTERS
·
Jul 14

Ironwood Appoints DR. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; Stars-2 Trial Initiated in June and is NOW Actively Recruiting Patients

THOMSON REUTERS
·
Jul 14

Ironwood CFO Ronald Silver Sells 127,890 Shares for $578,063.80

Reuters
·
Jul 10

Ironwood Pharmaceuticals shareholders approve 10 million-share increase to equity incentive plan

Reuters
·
Jun 19

Ironwood Pharma Director Julie McHugh disposes of 21,571 shares worth $80,449.83

Reuters
·
Jun 18

BRIEF-Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026

Reuters
·
Jun 16

Ironwood Pharmaceuticals - Funded Repayment of Notes Using Available Cash on Hand - SEC Filing

THOMSON REUTERS
·
Jun 16